Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05452330
Other study ID # Migren
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 18, 2022
Est. completion date September 16, 2022

Study information

Verified date July 2022
Source Biruni University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to compare the effects of connective tissue massage on pain severity, attack frequency and duration, migraine-related disability, and quality of life in patients diagnosed with migraine, by comparing them with the classical massage.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date September 16, 2022
Est. primary completion date September 9, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Volunteers with a migraine diagnosis - Taking only analgesics for migraine treatment and continuing their routines - No problem in reading, writing and understanding Turkish Exclusion Criteria: - Having any other neurological problems - Who had been injected with botulinum toxin in the last 3 months

Study Design


Intervention

Other:
Connective tissue massage
Connective tissue massage will be applied with short and long pulling strokes to create a reflex effect for 2 days a week, a total of 8 weeks.
Classical massage
Classical massage will be applied with the techniques of stroking, kneading, and friction for 2 days a week, a total of 8 weeks.

Locations

Country Name City State
Turkey Biruni University Istanbul Zeytinburnu

Sponsors (1)

Lead Sponsor Collaborator
Biruni University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Intensity The intensity of pain perceived by the subjects will be evaluated with a valid method, the Visual Analogue Scale (VAS). The higher numbers show higher pain intensities. 8 weeks
Secondary Migraine Related Disability The Migraine Disability Assessment Scale (MIDAS), which is considered valid and reliable, will be used to evaluate the migraine-related disability. The higher scores indicate an increase in the severity of the disability. 8 weeks
Secondary The Quality of Life The patients' quality of life will be evaluated with the 24-hours Quality of Life in Migraine Scale (24-Hr-MQoLQ), which is valid and reliable. The increase in the score obtained from the scale indicates an increase in the quality of life. 8 weeks
Secondary Perceived Patient-Reported Change The change perceived by the patients after the intervention will be evaluated with the Global Rating of Change Scale (GROC). According to the scale, it is expressed as "-2: I am much worse, -1: I am worse, 0: No change, 1: I am better, 2: I am much better". 8th week (one week)
Secondary The general descriptive demographic information The general descriptive demographic information of the participants such as age and gender; migraine family history, duration of the complaints, attack frequency and duration will be questioned with a form prepared by the researchers. 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05503082 - Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies Phase 4
Completed NCT04905654 - Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura N/A
Completed NCT04111484 - Adrenomedullin Effect on Migraine Without Patients N/A
Recruiting NCT04091789 - Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Phase 2
Completed NCT03337620 - Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine Phase 3
Completed NCT02259387 - Adolescents With Migraine: What's Stress Got To Do With It?
Completed NCT05658185 - Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient N/A
Completed NCT05001399 - Feasibility of Using Holographic Memory Resolution® (HMR) in Patients/Clients With Pain N/A
Completed NCT03490500 - Using the S100B Protein for Emergency Headache Management Care (S100)
Completed NCT03075020 - Carbon Monoxide Migraine-inducing Effects in Patients With Migraine Without Aura. N/A
Recruiting NCT03472092 - Mind and Body Approaches to Pain Reduction in Youth With Migraine Phase 2
Enrolling by invitation NCT04976985 - Osteopathic Manipulative Treatment and Migraine Headaches N/A
Active, not recruiting NCT04372264 - Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache Phase 4
Recruiting NCT04623203 - The Prognosis of Migraine and Tension-Type Headache in Children and Adolescents
Completed NCT04577443 - The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties. N/A
Completed NCT03560024 - The Effect of PACAP27 on the Extra- and Intracerebral Arteries Assessed by Magnetic Resonance Angiography (MRA) on Healthy Volunteers N/A
Completed NCT03228355 - Headache Inducing Effect of Cromakalim in Migraine Patients N/A
Completed NCT02438553 - Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain N/A
Recruiting NCT03577548 - Influence of Main Psychological and Social Factors on Primary Headaches
Recruiting NCT04715685 - Mind Body Balance for Pediatric Migraine N/A